| Primary |
| Hiv Infection |
69.4% |
| Antiretroviral Therapy |
16.8% |
| Tuberculosis |
2.8% |
| Hiv Test Positive |
2.3% |
| Retroviral Infection |
1.3% |
| Acquired Immunodeficiency Syndrome |
1.3% |
| Pulmonary Tuberculosis |
1.0% |
| Drug Use For Unknown Indication |
0.8% |
| Hepatitis C |
0.6% |
| Acute Hiv Infection |
0.5% |
| Antifungal Prophylaxis |
0.5% |
| Hepatitis B Virus Test |
0.4% |
| Hypertension |
0.4% |
| Neuropathy Peripheral |
0.3% |
| Product Used For Unknown Indication |
0.3% |
| Syphilis |
0.3% |
| Myocardial Infarction |
0.3% |
| Prophylaxis |
0.3% |
| Seminoma |
0.3% |
| Alcohol Abuse |
0.2% |
|
| Lactic Acidosis |
15.5% |
| Pregnancy |
10.3% |
| Pancreatitis |
8.6% |
| Neuropathy Peripheral |
8.0% |
| Progressive Multifocal Leukoencephalopathy |
6.9% |
| Vomiting |
5.7% |
| Immune Reconstitution Syndrome |
4.6% |
| Lymphadenopathy |
4.6% |
| Progressive External Ophthalmoplegia |
4.6% |
| Weight Decreased |
4.0% |
| Lipodystrophy Acquired |
3.4% |
| Maternal Exposure During Pregnancy |
3.4% |
| Periarthritis |
3.4% |
| Osteonecrosis |
2.9% |
| Ileal Atresia |
2.3% |
| Immune Reconstitution Inflammatory Syndrome |
2.3% |
| Mitochondrial Toxicity |
2.3% |
| Neoplasm Malignant |
2.3% |
| Neutropenia |
2.3% |
| Renal Failure |
2.3% |
|
| Secondary |
| Hiv Infection |
71.4% |
| Antiretroviral Therapy |
6.2% |
| Drug Use For Unknown Indication |
3.8% |
| Tuberculosis |
1.9% |
| Drug Exposure During Pregnancy |
1.8% |
| Acquired Immunodeficiency Syndrome |
1.6% |
| Prophylaxis |
1.5% |
| Antifungal Prophylaxis |
1.5% |
| Hepatitis C |
1.5% |
| Product Used For Unknown Indication |
1.1% |
| Human Immunodeficiency Virus Transmission |
1.0% |
| Antiviral Prophylaxis |
0.9% |
| Hypertension |
0.8% |
| Factor Viii Deficiency |
0.8% |
| Insomnia |
0.8% |
| Prophylaxis Against Hiv Infection |
0.8% |
| Mycobacterium Avium Complex Infection |
0.7% |
| Hiv Test Positive |
0.6% |
| Diffuse Panbronchiolitis |
0.6% |
| Gastritis |
0.6% |
|
| Weight Decreased |
11.9% |
| Vomiting |
9.1% |
| Progressive External Ophthalmoplegia |
8.2% |
| White Blood Cell Count Decreased |
7.7% |
| Portal Hypertension |
6.0% |
| Varices Oesophageal |
5.5% |
| Lactic Acidosis |
4.7% |
| Tuberculosis |
4.6% |
| Drug Resistance |
4.2% |
| Immune Reconstitution Syndrome |
4.2% |
| Pregnancy |
4.2% |
| Myocardial Infarction |
4.0% |
| Pancreatitis |
3.8% |
| Stillbirth |
3.6% |
| Drug Exposure During Pregnancy |
3.3% |
| Thrombocytopenia |
3.3% |
| Hyperlactacidaemia |
3.1% |
| Osteonecrosis |
3.1% |
| Hyperglycaemia |
2.7% |
| Liver Disorder |
2.7% |
|
| Concomitant |
| Hiv Infection |
55.6% |
| Drug Use For Unknown Indication |
16.0% |
| Product Used For Unknown Indication |
4.6% |
| Acquired Immunodeficiency Syndrome |
3.9% |
| Antiretroviral Therapy |
2.3% |
| Mycobacterium Avium Complex Infection |
1.9% |
| Prophylaxis |
1.9% |
| Diabetes Mellitus |
1.8% |
| Antifungal Prophylaxis |
1.7% |
| Systemic Antiviral Treatment |
1.3% |
| Tuberculosis |
1.1% |
| Antibiotic Prophylaxis |
1.1% |
| Hiv Test Positive |
1.1% |
| Gastrooesophageal Reflux Disease |
1.0% |
| Myocardial Infarction |
1.0% |
| Isosporiasis |
0.8% |
| Cytomegalovirus Infection |
0.8% |
| Trigeminal Neuralgia |
0.8% |
| Antiviral Prophylaxis |
0.7% |
| Hypertension |
0.7% |
|
| Vomiting |
17.4% |
| Rhabdomyolysis |
11.1% |
| Weight Decreased |
8.5% |
| Stevens-johnson Syndrome |
6.4% |
| Renal Failure |
6.0% |
| Blood Bilirubin Unconjugated Increased |
4.7% |
| Renal Failure Acute |
4.7% |
| Death |
3.8% |
| Myocardial Infarction |
3.8% |
| Pregnancy |
3.8% |
| Pyrexia |
3.8% |
| White Blood Cell Count Decreased |
3.8% |
| Lymphoma |
3.0% |
| Splenomegaly |
3.0% |
| Visual Disturbance |
3.0% |
| Visual Field Defect |
3.0% |
| Drug Resistance |
2.6% |
| Mitochondrial Toxicity |
2.6% |
| Osteonecrosis |
2.6% |
| Pathogen Resistance |
2.6% |
|
| Interacting |
| Blood Pressure Management |
33.8% |
| Hiv Infection |
29.6% |
| Systemic Antiviral Treatment |
16.9% |
| Acne |
5.6% |
| Neuropathy Peripheral |
4.2% |
| Alcohol Abuse |
2.8% |
| Drug Use For Unknown Indication |
2.8% |
| Convulsion |
1.4% |
| Hypertension |
1.4% |
| Insomnia |
1.4% |
|
| Renal Failure Acute |
44.4% |
| Hypertriglyceridaemia |
22.2% |
| Drug Interaction |
11.1% |
| Multi-organ Failure |
11.1% |
| Pancreatitis |
11.1% |
|
